Literature DB >> 2719500

Contributing diagnoses in osteoporosis. The value of a complete medical evaluation.

B E Johnson1, B Lucasey, R G Robinson, B P Lukert.   

Abstract

Osteoporosis often occurs as a consequence of, or is accelerated by, many medical diseases, drug exposures, or other conditions. We called these conditions contributing diagnoses. Although technological advances permit the accurate measurement of bone density, identifying osteoporosis without searching for contributing diagnoses may result in remediable diseases being missed or in the initiation of inadvisable therapy. The value of comprehensive medical evaluation in conjunction with appropriate diagnostic studies was demonstrated in an osteoporosis referral center. We studied 300 consecutive persons who presented to an osteoporosis clinic. Using strict criteria, 180 patients (60%) had osteoporosis. Of these 180 patients, 83 (46%) had one or more contributing diagnosis, ie, a condition thought to accelerate bone loss. The largest single group was composed of persons with past or present exposure to glucocorticoids; the second largest group consisted of women who had undergone premature menopause. In all, 27 different contributing diagnoses were identified. Additionally, in 19 (11%) of the 180 patients with osteoporosis, a contributing diagnosis new to those patients was made. The evaluation of osteoporosis does not only entail measurement of bone density but must also take into consideration a patient's entire medical milieu.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719500

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

3.  Utility of biochemical screening in the context of evaluating patients with a presumptive diagnosis of osteoporosis.

Authors:  C Rajeswaran; J Spencer; J H Barth; S M Orme
Journal:  Clin Rheumatol       Date:  2006-05-11       Impact factor: 2.980

Review 4.  Osteoporosis, frailty and fracture: implications for case finding and therapy.

Authors:  Joop P van den Bergh; Tineke A van Geel; Piet P Geusens
Journal:  Nat Rev Rheumatol       Date:  2012-01-17       Impact factor: 20.543

5.  Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

Authors:  J L Casado; S Bañon; R Andrés; M J Perez-Elías; A Moreno; S Moreno
Journal:  Osteoporos Int       Date:  2013-09-21       Impact factor: 4.507

6.  Pathogenesis of vertebral crush fractures in women.

Authors:  G A Caplan; A C Scane; R M Francis
Journal:  J R Soc Med       Date:  1994-04       Impact factor: 5.344

Review 7.  Osteoporosis: the evolution of a scientific term.

Authors:  D Schapira; C Schapira
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

8.  Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics.

Authors:  Jean-Michel Pouillès; Florence A Trémollieres; Claude Ribot
Journal:  Osteoporos Int       Date:  2005-07-15       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.